New Vernon Capital Holdings Ii LLC Catalyst Pharmaceuticals, Inc. Transaction History
New Vernon Capital Holdings Ii LLC
- $170 Million
- Q4 2024
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 5,822 shares of CPRX stock, worth $128,375. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,822Holding current value
$128,375% of portfolio
0.07%Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
345Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$412 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$186 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$128 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$69.1 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$66.4 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.27B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...